Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Withdrawn
- Conditions
- Blood Stem Cell Transplant Failure
- Registration Number
- NCT01569373
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.
- Detailed Description
To determine if serum biomarkers of inflammation correlate with onset and severity of acute GVHD, particularly GVHD of the gut.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- 18 years old or older patients
- Undergoing allogeneic stem cell transplant
Read More
Exclusion Criteria
None
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnosis of severe acute GVHD 2 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States